PFE Quantitative Stock Analysis June 24, 2025 — 09:39 am EDT. ... Detailed Analysis of PFIZER INC. PFE Guru Analysis. PFE Fundamental Analysis. More Information on Meb Faber.

The US stock market bounced back on Tuesday after the truce between Iran and Israel. The Dow Jones, Nasdaq 100, and S&P 500 ...

Discover why options trading trends, robust R&D, and strong free cash flow position Pfizer Inc. for growth. Click for my ...

Pfizer (NYSE: PFE) stock price has crashed hard in the past few years as demand for Covid-19 vaccines faded globally. It was trading at $28 on Monday, down from the pandemic high of $55.56. It has ...

The Pfizer stock's long-term trajectory looks predominantly bullish, as indicated in the quarterly chart. A closer look shows that between 1999 and 2009, there was a clear emergence of a bull flag ...

Pfizer’s financial outlook for 2025 has been a focal point for investors and analysts. The company has maintained its revenue guidance for fiscal year 2025 at $61.0-64.0 billion, with the COVID ...

In late 2021, Pfizer (PFE-0.21%) stock was at an all-time high. The company had pulled off a near miracle with its rapid development of a COVID-19 vaccine. It followed that success with the launch ...

Pfizer's (PFE) adjusted fourth-quarter profit of 63 cents a share beat the FactSet consensus estimate of 47 cents a share. Revenue rose rose 22% to $17.76 billion from $14.57 billion and beat the ...

Pfizer's (PFE 0.30%) management team is confident in its 2025 opportunities. *Stock prices used were the afternoon prices of May 20, 2025. The video was published on May 22, 2025.

Pfizer targets $1.5B savings by 2027 with a new cost-cutting plan focusing on operational efficiencies and restructuring. Technical analysis shows bullish momentum for Pfizer's stock, with prices ...

Pfizer Inc. (NYSE: PFE), a global biopharmaceutical giant with a market capitalization of $139.52 billion, finds itself at a critical juncture as it navigates a complex landscape of opportunities and ...